Addressing the Roots of Disparities in Cancer Care: Inherent Bias, Resources, and Insurance
March 23rd 2017At the 22nd Annual Conference of the National Comprehensive Cancer Network, held March 23-25, 2017, in Orlando, FL, policy researchers with interest in cancer care disparities discussed the source of existing disparities and how they can be successfully addressed.
Read More
ASCO's State of Cancer Care in America Report Addresses Access and Affordability Challenges
March 22nd 2017The report, which provides an update on all the monumental changes witnessed by the field of oncology over the last year, highlights 3 key achievements: new investments in science and insurance coverage, payment models that emphasize quality, and rapid-learning healthcare systems.
Read More
A Self-Persuasion App to Boost Adolescent HPV Vaccination Among Low-Income Families
March 8th 2017A pilot study conducted at a safety net hospital has armed researchers with a new educational tool: a digital app to persuade parents to vaccinate their adolescent against the human papilloma virus (HPV).
Read More
5 Takeaways From the PAN Foundation's Cost-Sharing Roundtable
March 3rd 2017The roundtable provides a forum for academic researchers, health policy experts, patient advocates, health insurance plans, and the pharmaceutical industry to debate on the most sustainable strategies for patient cost sharing for medications.
Read More
Insurance Status, Race, and Education Remain Persistent Barriers to Cancer Screening
March 2nd 2017While colorectal cancer screening rates have seen a recent progress toward achieving the Healthy People 2020 objectives, breast cancer screening rates have remained static, and cervical cancer screening rates have been declining.
Read More
The Uncertain Future of High-Need Medicare Beneficiaries
February 27th 2017At the 2nd cost-sharing roundtable hosted by the Patient Access Network Foundation and The American Journal of Managed Care®, Tricia Neuman of the Kaiser Family Foundation provided a perspective on what the future might hold for patients enrolled in Medicare.
Read More
Is Amgen's Outcomes-Based Contract in Response to Biosimilar Competition?
February 23rd 2017Amgen and Harvard Pilgrim Healthcare have entered an outcomes-based contract that is based on the efficacy of Amgen’s immunomodulatory agent etanercept (Enbrel), for patients with rheumatoid arthritis.
Read More
Integrating Patient-Centered Outcomes in APMs
February 22nd 2017As payment models shift to emphasize patient experience and quality of care, a panel discussion at the 5th annual Patient-Centered Oncology Care® meeting debated whether these efforts had meaningfully improved outcomes for patients.
Read More